⌘K

Home/Filings/4/0000950170-25-061881

4//SEC Filing

Bhanji Muna 4

Accession 0000950170-25-061881

CIK 0001652130other

View on SEC.gov Company Profile

Filed

Apr 30, 8:00 PM ET

Accepted

May 1, 4:24 PM ET

Size

4.6 KB

Accession

0000950170-25-061881

Insider Transaction Report

Form 4

Period: 2025-04-29

Intellia Therapeutics, Inc.NTLA

Director

Transactions

Sale
Common Stock
2025-04-29$8.50/sh−265$2,253→ 19,203 total

Footnotes (1)

[F1]The reported sale of 265 shares on this Form 4 occurred automatically pursuant to a 10b5-1 trading plan adopted by the reporting person on September 27, 2024.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Intellia Therapeutics, Inc.

CIK 0001652130

Entity typeother

Related Parties

1

filerCIK 0001846905

Filing Metadata

Form type: 4
Filed: Apr 30, 8:00 PM ET
Accepted: May 1, 4:24 PM ET
Size: 4.6 KB

View on SEC.gov